MENU

HALO Halozyme Therapeutics Forecast, Technical & Fundamental Analysis

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies... Show more

Industry: #Biotechnology
HALO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
HALO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

HALO is expected to report earnings to fall 1.75% to $2.24 per share on November 09

Halozyme Therapeutics HALO Stock Earnings Reports
Q3'26
Est.
$2.24
Q2'26
Beat
by $0.47
Q1'26
Beat
by $0.06
Q4'25
Missed
by $2.14
Q3'25
Beat
by $0.11
The last earnings report on August 06 showed earnings per share of $2.28, beating the estimate of $1.81. With 487.36K shares outstanding, the current market capitalization sits at 12.16B.
A.I. Advisor
published General Information

General Information

a developer of recombinant human enzymes for the infertility, ophthalmology and oncology markets

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
12390 El Camino Real
Phone
+1 858 794-8889
Employees
423
Web
https://www.halozyme.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FGL5.450.35
+6.86%
Founder Group Limited
RPM100.210.90
+0.91%
RPM International
ULH18.51-0.15
-0.80%
Universal Logistics Holdings
ANDE70.97-0.91
-1.27%
Andersons
OKYO1.40-0.03
-2.10%
OKYO Pharma Limited

HALO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HALO has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HALO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HALO
1D Price
Change %
HALO100%
+0.19%
AXON - HALO
47%
Loosely correlated
+0.10%
INCY - HALO
39%
Loosely correlated
-1.47%
GMAB - HALO
38%
Loosely correlated
+0.74%
VRTX - HALO
37%
Loosely correlated
+0.17%
ONC - HALO
35%
Loosely correlated
+1.38%
More
Halozyme Therapeutics (HALO) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com